Literature DB >> 12209627

Conversion of grass pollen allergen-specific human IgE into a protective IgG(1) antibody.

Sabine Flicker1, Peter Steinberger, Lars Norderhaug, Wolfgang R Sperr, Yasamin Majlesi, Peter Valent, Dietrich Kraft, Rudolf Valenta.   

Abstract

More than 100 million individuals exhibit IgE-mediated allergic reactions against Phl p 2, a major allergen from timothy grass pollen. We isolated cDNA coding for three Phl p 2-specific human IgE antibodies from a combinatorial library, which was constructed from lymphocytes of a grass pollen-allergic patient. Recombinant Phl p 2-specific IgE antibody fragments (Fab) recognized a fragment comprising the 64 N-terminal amino acids of Phl p 2 and cross-reacted with group 2 allergens from seven grass species. cDNA coding for the variable regions of one of the IgE Fab were cloned into aplasmid vector expressing the constant region of human IgG(1) to obtain a complete, recombinant Phl p 2-specific human IgG(1). This antibody blocked the binding of grass pollen-allergic patients IgE (n=26; mean inhibition: 58%) to Phl p 2 and caused a 100-fold reduction of Phl p 2-induced basophil histamine release. The recombinant human Phl p 2-specific IgG(1) may be used for environmental allergen detection, for standardization of diagnostic as well as therapeutic grass pollen allergen preparations and for passive therapy of grass pollen allergy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12209627     DOI: 10.1002/1521-4141(200208)32:8<2156::AID-IMMU2156>3.0.CO;2-A

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  25 in total

1.  Structural and immunologic cross-reactivity among filarial and mite tropomyosin: implications for the hygiene hypothesis.

Authors:  Helton C Santiago; Sasisekhar Bennuru; Alexis Boyd; Mark Eberhard; Thomas B Nutman
Journal:  J Allergy Clin Immunol       Date:  2010-12-24       Impact factor: 10.793

2.  The molecular basis of peanut allergy.

Authors:  Geoffrey A Mueller; Soheila J Maleki; Lars C Pedersen
Journal:  Curr Allergy Asthma Rep       Date:  2014-05       Impact factor: 4.806

Review 3.  Structural Analysis of Recent Allergen-Antibody Complexes and Future Directions.

Authors:  Geoffrey A Mueller; Jungki Min; Alexander C Y Foo; Anna Pomés; Lars C Pedersen
Journal:  Curr Allergy Asthma Rep       Date:  2019-02-28       Impact factor: 4.806

Review 4.  Immunology in the Clinic Review Series; focus on allergies: basophils as biomarkers for assessing immune modulation.

Authors:  S U Patil; W G Shreffler
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

5.  Nature of regulatory T cells in the context of allergic disease.

Authors:  Cevdet Ozdemir; Mübeccel Akdis; Cezmi A Akdis
Journal:  Allergy Asthma Clin Immunol       Date:  2008-09-15       Impact factor: 3.406

6.  Quantification, epitope mapping and genotype cross-reactivity of hepatitis B preS-specific antibodies in subjects vaccinated with different dosage regimens of BM32.

Authors:  Inna Tulaeva; Carolin Cornelius; Petra Zieglmayer; René Zieglmayer; René Schmutz; Patrick Lemell; Milena Weber; Margarete Focke-Tejkl; Alexander Karaulov; Rainer Henning; Rudolf Valenta
Journal:  EBioMedicine       Date:  2020-08-24       Impact factor: 8.143

Review 7.  Contributions and Future Directions for Structural Biology in the Study of Allergens.

Authors:  Geoffrey A Mueller
Journal:  Int Arch Allergy Immunol       Date:  2017-10-10       Impact factor: 2.749

Review 8.  Strategies to query and display allergy-derived epitope data from the immune epitope database.

Authors:  Kerrie Vaughan; Bjoern Peters; Mark Larche; Anna Pomes; David Broide; Alessandro Sette
Journal:  Int Arch Allergy Immunol       Date:  2012-11-21       Impact factor: 2.749

Review 9.  Current immunological approaches for management of allergic rhinitis and bronchial asthma.

Authors:  Deepsikha Srivastava; Naveen Arora; Bhanu Pratap Singh
Journal:  Inflamm Res       Date:  2009-03-31       Impact factor: 4.575

10.  Characterization of an anti-Bla g 1 scFv: epitope mapping and cross-reactivity.

Authors:  Geoffrey A Mueller; John A Ankney; Jill Glesner; Taruna Khurana; Lori L Edwards; Lars C Pedersen; Lalith Perera; Jay E Slater; Anna Pomés; Robert E London
Journal:  Mol Immunol       Date:  2014-03-22       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.